NASDAQ:VKTX

Viking Therapeutics Stock Predictions

Healthcare > Biotechnology

Buy VKTX

*Your capital is at risk

$29.33

+0.0400 (+0.137%)

At Close: Jun 03, 2026

Currently predicting for Thu, 4 Jun 2026

VKTX Prediction Chart

VKTX Predictions History

Latest community submissions for VKTX.

Predictor	Target Session	Target Price	Result	Direction	Accuracy	Score
PumpTheseNumbers Pro	Apr 8, 2019	$10.50 -0.85%	$10.59	X	99.15%	2
Gp Merchant @Gp.98898	Apr 8, 2019	$10.76 +1.61%	$10.59	X	98.39%	0
ss @ss.85868	Apr 8, 2019	$10.48 -1.04%	$10.59	X	98.96%	1
PumpTheseNumbers Pro	Mar 4, 2019	$8.50 -2.30%	$8.70	X	97.70%	0
PumpTheseNumbers Pro	Feb 26, 2019	$8.55 +0.71%	$8.49	X	99.30%	3
JS Pro	Feb 26, 2019	$8.73 +2.83%	$8.49	X	97.20%	0
JS Pro	Feb 26, 2019	$8.73 +2.83%	$8.49	X	97.20%	0
Gp Merchant @Gp.98898	Feb 26, 2019	$8.67 +2.12%	$8.49	X	97.90%	0
Cody.Long.98847	Jan 29, 2019	$6.35 -19.82%	$7.92	X	80.20%	0
JS Pro	Sep 20, 2018	$19.71 +3.90%	$18.97	X	96.10%	0

Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for VKTX with a full price path, not just a one-day call.

Price path
Approved predictor
3-month horizon

Start Forecast Request View My Forecast Requests

Featured Predictors

GPT 5.4 Reply target 48h

Select

Gemini 3.5 Reply target 48h

Select

Opus 4.7 Reply target 48h

Select

ABOUT VIKING THERAPEUTICS

Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trials to treat patients with biopsy-confirmed non-alcoholic steatohepatitis, as well as NAFLD. It also dev...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
LITE $905.00	3.65%	Jun 01
RUN $12.83	15.74%	May 06
GLBE $31.61	0.569%	May 05
SAP $172.39	4.80%	May 05
ADBE $243.57	5.20%	Apr 29

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by